Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I expect a complete Corporate Makeover
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I believe we are in complete agreement re: the SHM in Chicago. But it seems your discussion there doesn't fit with your list of expectations for the meeting, unless you think those expectations are all negative actions for retail shareholders. Personally, I still think the SHM will be, for the most part, a non-event. Baroni and Company are not expected to present their findings to the BoD until year end (per Baroni), so they'd have to react PDQ to enable anything to happen to be reportable at the SHM. Possible, but unlikely IMO.

In the interest of friendly discussion, I'll offer my take on each of your expectations recognizing that you expect them very near term (i.e., next Monday):

* Engagement of a significant Operating Partner
Possible at SHM (after Baroni assessment complete), but they'd have to move fast.
* Announcement of plans for a corporate acquisition, asset sale, or possibly even Merger.
We already know of the one divestiture (Iameter), but with the recently stated company interest in preserving capital, I wouldn't expect an acquisition or merger (as IMO any merger IS ultimately an acquisition by one of the parties). I suppose that an additional divestiture is possible, but IMO unlikely.
* Arrangement of a Stock Swap, or Private Stock Sale (Common or Preferreds)
Why? As part of an acquisition/merger? It would preserve cash on hand.
* Introduction of no fewer than 2 new BOD candidates, possibly as many as 4 new ones.
Again why? So they can put more people on the gravy train and have to share the booty, and the power? One caveat: maybe Baroni and cohort.
* Appointment of a BOD Chairman, and new Management team
Chairman maybe. Management team highly unlikely IMO because, again, Baroni's assessment isn't expected till year end, and the selection(s) are, per the company, predicated on the results of the assessment. Same caveat as above re: management team.
* Corporate Name Change from Patriot Scientific Corporation
Why? To confuse the market and all litigation history? IMO such action would be mindboggling - spend money for nothing but confusion.
* Reorganized and a more aggressive MMP Licensing/Prosecution campaign
This is not PTSC's obligation per the Master Agreement, and because of the terms of that agreement they'd have a heck of a time doing anything along these lines without total cooperation with TPL. Why should PTSC pay dollar one for such action (that they are not equipped to do) when they are not the sole beneficiary? If there is any action along these lines, it should be funded by PDS IMO. I'd be irrate if they suggested such action funded solely by PTSC. I do recognize that you are suggesting an action and not necessarily what entity will carry the ball/cost.
* Revised "target focus" for the Umbrella Strategy
While I wouldn't expect to see this in the Proxy, I would expect this to be a focus of discussion at the SHM. No specific details, other than planned target market. So I agree re: SHM.
* A professional, experienced and genuine effort for better Investor Relations.
This would be a big surprise! Proxy, no. SHM, it would be smart of them to at least designate a "permanent" IR rep.
I find it interesting that you suggest such vigorous action/planning by our BoD.
Your input is thought provoking. Thank you. It certainly prompted a great deal more interest in the proxy and SHM for me! Gosh, maybe something will actually happen!
JMHOs, in near complete ignorance, 'cuz I KNOW nuttin'!
SGE
3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply